Arbutus Biopharma
ABUS
#6379
Rank
C$1.39 B
Marketcap
C$7.02
Share price
-1.18%
Change (1 day)
15.05%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): C$0.99

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is C$1.01. In 2025 the company made an earnings per share (EPS) of C-$0.24 an increase over its 2024 EPS that were of C-$0.53.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.99-517.17%
2025C-$0.24-55.26%
2024C-$0.53-13.64%
2023C-$0.62-4.35%
2022C-$0.64-44.58%
2021C-$1.16-17%
2020C-$1.40-65.4%
2019C-$4.05138.84%
2018C-$1.70-22.44%
2017C-$2.19-78.45%
2016C-$10.15424.64%
2015C-$1.93-20.19%
2014C-$2.4287.96%
2013C-$1.29-142.59%
2012C$3.03-342.7%
2011C-$1.25-25.82%
2010C-$1.6847.8%
2009C-$1.14-43.55%
2008C-$2.02158.91%
2007C-$0.78-111.88%
2006C$6.56-552.53%
2005C-$1.45-71.77%
2004C-$5.13-14.48%
2003C-$6.00-8.95%
2002C-$6.5970.07%
2001C-$3.8748.01%
2000C-$2.62-38.54%
1999C-$4.26-24.6%
1998C-$5.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
C-$0.08412-108.33% Bahamas
NRC Health
NRC
C$0.55-45.83%๐Ÿ‡บ๐Ÿ‡ธ USA